Today: 9 June 2026
Browse Category

ASX:CSL 24 December 2025 - 26 January 2026

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL Ltd shares closed 0.7% higher at A$179.62 Friday, extending Thursday’s gains, with 1.01 million shares traded. The stock’s rise comes as U.S. vaccine policy changes under Health Secretary Robert F. Kennedy Jr. weigh on sentiment for CSL’s Seqirus unit. CSL delayed a Seqirus spinoff and cut its 2026 growth forecast in October, citing falling U.S. flu vaccination rates. Half-year results are due Feb. 11.
23 January 2026
···
CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL shares closed down 0.33% at A$176.11 on Wednesday, staying well below last year’s highs. RBC Capital upgraded CSL to “Outperform” and raised its price target to A$230, citing valuation upside despite weak U.S. flu vaccine demand. Investors are focused on CSL’s half-year results and interim dividend due Feb. 11. The S&P/ASX 200 slipped 0.37% amid broader market volatility.
21 January 2026
··
CSL share price edges up after RBC upgrade as investors eye February results

CSL share price edges up after RBC upgrade as investors eye February results

CSL shares rose 0.1% to A$176.70 Tuesday after RBC Capital Markets upgraded the stock, despite the ASX 200 falling 0.66%. The move follows a 36% drop in CSL’s share price over the past year and comes ahead of its Feb. 11 half-year results. RBC cited competition and weak flu vaccine demand as near-term risks. CSL last cut its 2026 revenue and profit growth forecasts in October and delayed its Seqirus spin-off.
20 January 2026
·
CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL Ltd shares fell 1.0% to A$173.32 Tuesday, underperforming the S&P/ASX 200, which rose 0.56%. The drop follows last year’s cut to CSL’s FY26 forecasts and a delay to the Seqirus spin-off after a sharp decline in U.S. flu vaccinations. No new company updates were released Tuesday. CSL’s next scheduled disclosure is its half-year results on Feb. 11.
13 January 2026
···
CSL Limited (ASX:CSL) Stock Update on 24 December 2025: Share Price Drops, Buyback Progress, Seqirus Uncertainty, and 2026 Analyst Forecasts

CSL Limited (ASX:CSL) Stock Update on 24 December 2025: Share Price Drops, Buyback Progress, Seqirus Uncertainty, and 2026 Analyst Forecasts

CSL Limited shares closed at A$171.48 on 24 December 2025, down 2.38%, near their 52-week low of A$168.00. The company delayed the spin-off of its Seqirus vaccine arm and cut its FY26 outlook after a sharper-than-expected drop in US flu vaccination rates. Market value stands at about A$85.5 billion. Shares are down roughly 39% over the past year.
24 December 2025
·
1 2 3 4

Stock Market Today

  • Uranium Energy Shares Fall 17% on Larger Q3 Loss Despite New Production Start
    June 9, 2026, 4:11 PM EDT. Uranium Energy Corp shares fell 17% to $10.43 after reporting a fiscal third-quarter net loss of $52.3 million, up from $30.2 million a year earlier. The Texas-based uranium miner began production at its Burke Hollow project, using in-situ recovery (ISR), which extracts uranium by dissolving ore underground. The company ended the quarter with $794 million in liquid assets and no debt. Weak sales of purchased uranium inventory contributed to the loss, dropping gross profit from sales to $10 million from $24.5 million last year. CEO Amir Adnani highlighted ongoing challenges in uranium conversion, a key step for nuclear fuel production. Despite falling shares, UEC expects production to rise in the fourth quarter as new facilities at Burke Hollow and Christensen Ranch operate fully. Market uranium prices remained stable near $85.70 per pound.

Latest articles

Dow Edges Up 16 Points, Nasdaq Falls After Bell

Dow Edges Up 16 Points, Nasdaq Falls After Bell

9 June 2026
Tech stocks plunged, dragging the Nasdaq down 1.21% as investors dumped AI and chip shares ahead of key inflation data and after President Trump called for a U.S. response to Iran’s downing of a U.S. helicopter; the Dow edged up just 16 points as volatility spiked to its highest since April 7.
POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

9 June 2026
POET Technologies plunged 13% to $10.65 as renewed class-action reminders and April’s Marvell/Celestial AI order cancellation kept legal and execution risks in focus, outweighing a $50 million Lumilens order and $400 million financing, while broader AI chip stocks also slumped.
Uranium Energy Drops 17% After Reporting Q3 Loss

Uranium Energy Drops 17% After Reporting Q3 Loss

9 June 2026
Uranium Energy shares plunged 17% to $10.43 after reporting a wider Q3 net loss of $52.3 million and no uranium inventory sales, overshadowing the start of production at Burke Hollow; heavy volume and a sharper drop than peers reflected investor concerns over execution risks and near-term earnings despite strong cash and no debt.
Go toTop